<DOC>
	<DOCNO>NCT03085576</DOCNO>
	<brief_summary>A non-interventional , national longitudinal study atrial fibrillation perform 186 cardiologist .</brief_summary>
	<brief_title>NATional TUnisian REgistry Atrial Fibrillation</brief_title>
	<detailed_description>The NATURE-AF study carry Tunisia cardiology consultation hospital liberal sector . A total 186 cardiologist participate selection patient investigator . The study longitudinal non-interventional registry atrial fibrillation . The data collect manage DACIMA Clinical Suite® platform , comply international standard : FDA 21 CFR part 11 ( Food Drug Administration 21 Code Federal Regulations part 11 ) , HIPPA ( Health Insurance Portability Accountability Act ) , ICH ( International Conference Harmonisation ) , MedDRA ( Medical Dictionary Regulatory Activities ) . The DACIMA Clinical Suite® platform allow track data enter , check inconsistency miss data , schedule monitoring visit . A Steering Committee set monitor patient inclusion , verify data source , perform audit trail prepare statistical analysis plan study .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>At least one episode atrial fibrillation , document 12lead ECG / rhythmic holter ( duration episode : 30 second ) Recent atrial fibrillation diagnose less year Regular monitoring every 3 month ensure Informed , read sign consent Estimated life expectancy le 12 month Transient atrial fibrillation due reversible cause ( eg acute myocardial infarction , follow cardiac surgery , acute alcohol intoxication , hyperthyroidism , pulmonary embolism acute pulmonary disease , pericarditis , myocarditis , hydroelectrolyte disorder , metabolic disorder ) Cardiac surgery ≤ 3 month Atrial flutter isolate without atrial fibrillation Mental disorder Ongoing anticoagulation reason atrial fibrillation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Anticoagulation</keyword>
	<keyword>Stroke</keyword>
	<keyword>Vitamin K antagonist</keyword>
	<keyword>Cardioversion</keyword>
	<keyword>INR ( International Normalized Ratio )</keyword>
</DOC>